TwinBeech Capital’s Usana Health Sciences USNA Stock Holding History

TwinBeech Capital’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,218	Closed	-$383K	–	589
2020 Q2	$383K	Buy	+5,218	New	+$409K	0.08%	266

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TwinBeech Capital's USNA Position: Q3 2020 in Review

TwinBeech Capital sold out of Usana Health Sciences (USNA) in Q3 2020, closing a stake of 5,218 shares — an estimated $383K sold.

TwinBeech Capital first reported a position in USNA in Q2 2020 and held it in 1 quarter. The position peaked at $383K in Q2 2020. 192 funds tracked by Wall St. Rank hold USNA as of Q3 2020.

TwinBeech Capital reported no remaining Usana Health Sciences position as of Q3 2020 after selling out during the quarter.
TwinBeech Capital sold 5,218 Usana Health Sciences shares in Q3 2020, an estimated $383K.
TwinBeech Capital first reported a position in Usana Health Sciences in Q2 2020 and held it in 1 quarter.
TwinBeech Capital's Usana Health Sciences position peaked at $383K in Q2 2020.
192 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2020.

Based on TwinBeech Capital's 13F filing for Q3 2020, filed 16 Nov 2020.